Goldman Sachs’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
– Sell
-35,000
Closed -$416K – 7236
2014
Q3
$416K Sell
35,000
-39,600
-53% -$525K ﹤0.01% 5443
2014
Q2
$1.13M Buy
74,600
+15,800
+27% +$219K ﹤0.01% 4586
2014
Q1
$841K Buy
+58,800
New +$873K ﹤0.01% 4849
2013
Q4
– Sell
-45,500
Closed -$552K – 6746
2013
Q3
$552K Hold
45,500
– – ﹤0.01% 5095
2013
Q2
$507K Buy
+45,500
New +$488K ﹤0.01% 4926

Other funds holding MMSI

Goldman Sachs's MMSI Position: Q2 2026 in Review

Goldman Sachs reduced its Merit Medical Systems (MMSI) stake by 22% in Q2 2026, selling an estimated $9.21M and leaving 508,223 shares worth $35.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2112.

Goldman Sachs first reported a position in MMSI in Q2 2013 and has held it in 52 quarters since. The position peaked at $83.6M in Q4 2025. 405 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.

  • Goldman Sachs held 508,223 shares of Merit Medical Systems worth $35.2M as of Q2 2026.
  • Goldman Sachs sold 139,571 Merit Medical Systems shares in Q2 2026, an estimated $9.21M.
  • Merit Medical Systems made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2112 holding.
  • Goldman Sachs first reported a position in Merit Medical Systems in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Merit Medical Systems position peaked at $83.6M in Q4 2025.
  • 405 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.